Selegiline Patch for Treatment of Nicotine Dependence

NCT01330030 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

243

Enrollment

OTHER

Sponsor class

Conditions

Tobacco Use Disorder

Interventions

DRUG: Selegiline
OTHER: matching placebo

Sponsor

Stanford University

Collaborators

[object Object]